The document is a regulatory filing containing the transcript of a post-results conference call for investors and analysts discussing the company's Q1 FY27 financial results.
The virtual event was organized on Wednesday, July 29, 2026, at 03:00 P.M. IST.
The stated purpose was to discuss the company's Q1 FY27 performance and provide a business update.
The meeting was scheduled after the quarterly earnings announcement.
Key management participants included:
Mr. Kedar Vaze, Whole-Time Director and Group CEO
Mr. B. Ramakrishnan, CEO, Fragrances, Asia and U.S.A.
Mr. Jagdish Agarwal, Group Chief Financial Officer
The company explicitly stated that no unpublished price sensitive information (UPSI) was shared during the call.
Financial Highlights Discussed:
The consolidated revenue from operations grew 14% Y-o-Y to Rs. 662 crore.
The Fragrance segment delivered healthy growth led by Europe and select international markets.
The Flavour segment recorded strong broad-based growth across geographies, contributing Rs. 112 crore for the quarter. Management noted that approximately Rs. 15-17 crore of this was due to customer preponement of orders and should not be extrapolated for the full year. A normalized quarterly run rate is estimated at Rs. 95-96 crore.
Gross margins were stable year-on-year.
Consolidated EBITDA rose 21% to Rs. 89 crore, with the EBITDA margin improving to 13.4% from 12.6% in Q1 FY26.
The company recognized exceptional income of approximately Rs. 30 crore from an insurance claim related to a fire incident. The total claim is estimated at Rs. 80-90 crore, with full settlement expected within FY27.
Net debt increased by Rs. 65 crore during the quarter to Rs. 852 crore as of June 2026, attributed to strategic inventory buildup and ongoing capacity expansion.
The effective tax rate (ETR) for the quarter was approximately 31.5-32%. The company's target is to bring this below 30%.
Strategic and Operational Updates:
Management highlighted continued investments in R&D and Creative Development Centers (CDCs) in new markets (Germany, U.S.A., U.K.), which are weighing on near-term segment margins but are considered central to future growth.
The market opportunity in the U.S. and U.K. is estimated to be 4-5x larger than the Indian fragrance market.
The company is targeting a long-term Return on Capital Employed (ROCE) of 17-20%.
Capex for the quarter was Rs. 25 crore, primarily in Europe. The European capex is now completed, and the plant is operational since May.
Capex for Q2 is estimated at Rs. 25 crore for the Vanvate project in India, which is expected to be commissioned in Q3 FY27.
Total planned capex for the year is approximately Rs. 100 crore across three plants in India.
The company expects to begin deleveraging and reducing debt by approximately Rs. 25 crore per quarter starting from Q3 FY27.
The depreciation run rate is expected to increase from ~Rs. 35 crore per quarter to Rs. 38-39 crore per quarter after new capacity capitalizations.
The company provided full-year guidance for double-digit revenue growth and improved margins for FY27, though it cautioned that quarterly variations are expected due to demand timing and geopolitical situations.
Additional Notes Section
The document was an enclosure to a formal regulatory submission to BSE Limited and the National Stock Exchange of India Limited.
The transcript was included as an attachment to the filing.
The document contained extensive financial data and commentary from the earnings call.
